Emergency Medicine Specialty Recertification Literature Study: Module 1A-C (L269103)
ACPE Numbers: Various – see listing below
Content Release Date: 07/15/2026
Expiration Dates: 07/13/2027
Activity Type: Application-based
CE Credits: 10 hours (BPS and ACPE)
Activity Fee: $65 (ASHP member); $120 (non-member)
Activity Overview
The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 3 online home study activities (see table below). Each activity is designed to assess the learner’s ability to analyze and apply peer-selected contemporary articles to practice.
Module 1A – Infectious Diseases: This module focuses on infectious diseases issues such as complicated urinary tract infections, bacterial vaginosis and antibiotic stewardship in the emergency department.
Module 1B – Pediatrics: This module focuses on pediatric issues such as pain, sedation, agitation, emergency cardiovascular care, and gastroenteritis in the emergency department.
Module 1C – Cardiology: This module focuses on cardiovascular issues including acute coronary syndromes, supraventricular tachycardia, and advanced cardiovascular life support in the emergency department.
Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.
These activities are part of the ASHP and ACCP professional development program for BCEMP recertification approved by the BPS.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
These Literature Studies are designed to help board-certified pharmacists who are seeking recertification contact hours to maintain their Board of Pharmacy Specialties (BPS).
Recertification Credit
Board certified pharmacists are eligible to receive up to 10 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.
ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.
![]()
ASHP and ACCP are approved by BPS as providers for the recertification of BCEMP.
|
Learning Activity |
ACPE Number |
Contact Hours (ACPE and BPS) |
Assessment Pass Point |
|
Module 1A: Infectious Diseases |
0204-9999-26-932-H01-P |
3.0 |
73% |
|
Module 1B: Pediatrics |
0204-9999-26-933-H01-P |
4.0 |
80% |
|
Module 1C: Cardiology |
0204-9999-26-933-H01-P |
3.0 |
73% |
Articles and Learning Objectives
Module 1A: Infectious Diseases
ACPE #: 0204-9999-26-932-H01-P
This module focuses on infectious diseases issues such as complicated urinary tract infections, bacterial vaginosis and antibiotic stewardship in the emergency department.
Trautner BW, Cortes-Penfield NW, Gupta K, et al. Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infection. July 17, 2025. https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/
- Describe the 2025 clinical practice guideline from the Infectious Diseases Society of America (IDSA) on management and treatment of complicated urinary tract infection
- Develop recommendations for the treatment of patients with complicated urinary tract infection (UTI)
Koehl J, Spolsdoff D, Negaard B, Lewis A, Santiago R, Krenz J, Polotti A, Feldman R, Slocum G, Zimmerman D, Howington GT, Sarangarm P, Mattson AE, Brown C, Zepeski A, Rech MA, Faine B. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025 Mar;85(3):240-248. doi: 10.1016/j.annemergmed.2024.10.013. Epub 2024 Nov 20. PMID: 39570254.
- Describe the COPY-ED study by Koehl and colleagues comparing the use of oral cephalosporins with fluroquinolones or trimethoprim/sulfamethoxazole (TMP-SMX) for treatment of pyelonephritis after discharge home from the emergency department
- Develop recommendations for the prescribing of empiric antibiotic therapy in the emergency department (ED) for outpatient use to treat pyelonephritis at home
Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N Engl J Med 2025; 392: 947 - 957.
- Describe the StepUp study by Vodstrcil and colleagues of the impact of male partner treatment on the recurrence of bacterial vaginosis
- Develop recommendations for the treatment of bacterial vaginosis to minimize the risk of recurrence
Draper HM, Rybak MJ, LaPlante KL, Lodise T, Sakoulas G, Burk M, Cunningham FE. Antibiotic stewardship in the emergency department setting: focus on oral antibiotic selection for adults with skin and soft tissue infections. Am J Health-Syst Pharm. 2024;81(21):e677-e683. doi: 10.1093/ajhp/zxae163. PMID: 38965915; PMCID: PMC11497082.
- Describe the special feature article by Draper and colleagues about an expert advisory panel’s suggested strategies for antibiotic stewardship in the treatment of skin and soft tissue infections (SSTIs), with a focus on oral antibiotic use in the emergency department (ED) setting for adults who will be treated as outpatients.
- Develop recommendations for antibiotic stewardship in the use of oral antibiotics for the treatment of skin and soft tissue infections (SSTIs) in the emergency department (ED) setting for adults who will be treated as outpatients
Module 1B: Pediatrics
ACPE #: 0204-9999-26-933-H01-P
This module focuses on pediatric issues such as pain, sedation, agitation, emergency cardiovascular care, and gastroenteritis in the emergency department.
Lasa JJ, Dhillon GS, Duff JP, et al. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2025; 152 (suppl 2): S479 – S537.
- Describe the 2025 American Heart Association (AHA) and American Academy of Pediatrics (AAP) pediatric advanced life support (PALS) guidelines for cardiopulmonary resuscitation and emergency cardiovascular care pertaining to drug administration during cardiac arrest; post-cardiac arrest care, treatment, and monitoring; management of shock; atropine use for emergency intubation; treatment of tachyarrhythmias; and management of pulmonary hypertension, including treatment of infants and children with pulmonary hypertensive crises
- Develop recommendations for drug administration during cardiac arrest; post-cardiac arrest care, treatment, and monitoring; management of shock; atropine use for emergency intubation; treatment of tachyarrhythmias; and management of pulmonary hypertension in pediatric patients
Tilley H, Enderby A, VanWert E, Choi S. Trends in pediatric emergency medicine: focus on behavioral health, substance use, and safety. Am J Health-Syst Pharm. 2025;, zxaf127, https://doi.org/10.1093/ajhp/zxaf127
- Describe recent trends in medication errors, behavioral health emergencies, and substance use involving children and adolescents within and outside the emergency department and approaches to optimizing pharmacotherapeutic care for this high-risk patient population
- Develop recommendations to improve the level of pediatric readiness in the emergency department and provide pharmacotherapeutic care for children and adolescents with behavioral health emergencies or substance use
Mills KP, Kemper M, Charatcharungkiat N, Hoganson GM. Pharmacotherapy considerations for pediatric acute agitation management in the emergency department. Am J Health Syst Pharm. 2024;81(23):e727-e741
- Describe the risk factors for acute agitation and the efficacy and safety of pharmacotherapies for its management in pediatric patients in the emergency department based on available literature
- Develop recommendations for the management of acute agitation in pediatric patients in the emergency department
Gwarzo I, Coleman KD, McKinley K, et al. Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain. JAMA Pediatr. Published online September 02, 2025. doi:10.1001/jamapediatrics.2025.2967
- Describe the study by Gwarzo and colleagues of the relationship between the timing of administration of opioids to pediatric patients with acute sickle cell disease (SCD) pain in the emergency department and hospital admissions for SCD pain
- Develop recommendations for the timing of administration of opioids to pediatric patients with acute uncomplicated sickle cell disease (SCD) pain in the emergency department
Del Pizzo J; Fein JA, MPH. Oral Ketamine and Midazolam for Procedural Sedation in the Pediatric Emergency Department: A Retrospective Study. Pediatric Emergency Care 41(2):p 122-126, February 2025. DOI: 10.1097/PEC.0000000000003291
- Describe the study by Del Pizzo and Fein of oral ketamine and midazolam for procedural sedation in pediatric patients in the emergency department
- Develop recommendations for the use of needle-free procedural sedation in pediatric patients in the emergency department
Freedman SB, Williamson-Urquhart S, Plint AC, et al. Multidose ondasetron after emergency visits in children with gastroenteritis. N Engl J Med 2025; 393: 255 - 266.
- Describe the study by Freedman and colleagues of postdischarge use of ondansetron in pediatric patients with acute gastroenteritis-associated vomiting who are treated in the emergency department
- Develop recommendations for provision of ondansetron at the time of discharge from the emergency department to pediatric patients with acute gastroenteritis-associated vomiting
Module 1C: Cardiology
ACPE #: 0204-9999-26-934-H01-P
This module focuses on cardiovascular issues including acute coronary syndromes, supraventricular tachycardia, and advanced cardiovascular life support in the emergency department.
Hyland SJ, Eaton RE, Max ME, Egbert SB, Wong SA, Blais DM. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist's role, part 1: Patient presentation through revascularization. Am J Health Syst Pharm. 2025 Jun 26;82(13):e578-e595. doi: 10.1093/ajhp/zxae303. PMID: 39450757.
- Describe the key pharmacotherapeutic modalities and considerations for patients with acute ST-elevation myocardial infarction (STEMI) and the pharmacist’s role in the critical initial phases of care
- Develop recommendations for patients with ST-elevation myocardial infarction (STEMI) during the critical initial phases of care between the time of patient presentation and revascularization
Krug N, Baize P, Barre S, Barnes R, Weigartz K. Comparison of initial adenosine dose conversion rate for supraventricular tachycardia in the emergency department. Am J Emerg Med 2024; 85: 117 - 122
- Describe the study by Krug and colleagues of adenosine in patients with supraventricular tachycardia (SVT) presenting to the emergency department (ED)
- Develop recommendations for the use of adenosine in patients with supraventricular tachycardia (SVT) presenting to the emergency department (ED)
Wigginton JG, Agarwal S, Bartos JA, et al. Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2025; 152 (Suppl 2): S538 - 577.
- Describe the 2025 American Heart Association (AHA) adult advanced life support guidelines for cardiopulmonary resuscitation and emergency cardiovascular care pertaining to the use of vasopressor and nonvasopressor medications in adults in cardiac arrest, management of adults with tachycardia, and treatment of adults with atrial fibrillation or flutter and rapid ventricular response
- Develop recommendations for the use of vasopressor and nonvasopressor medications in adults in cardiac arrest, management of adults with tachycardia, and treatment of adults with atrial fibrillation or flutter and rapid ventricular response
Faculty
Heather Draper, PharmD, BCPS, BCEMP*
Clinical Pharmacy Specialist, Emergency Medicine
Trinity Health Grand Rapids
Grand Rapids, Michigan
Lauren Floris, PharmD, BCPS
Clinical Pharmacist
Atrium Health Navicent Medical Center
Macon, Georgia
Curtis Geier, PharmD, BCEMP
Emergency Medicine Clinical Pharmacist
San Francisco General Hospital and Trauma Center
San Francisco, California
Jennifer Hoh, PharmD, BCCCP, BCEMP
Interim Director, Experiential Education; Assistant Professor of Pharmacy Practice
Jefferson College of Pharmacy, Thomas Jefferson University
Philadelphia, Pennsylvania
Daniel Jarrell, PharmD, BCCCP, BCPS
Acute Care Clinical Pharmacists Specialist - Emergency Medicine
Banner Health
Tucson, Arizona
Samantha Luciana, PharmD, BCPS, BCEMP
Clinical Pharmacy Specialist, Emergency Medicine
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania
Ashley Martinelli, PharmD, BCEMP
Clinical Pharmacy Specialist, Emergency Medicine
University of Maryland Medical Center
Baltimore, Maryland
Megan Musselman, PharmD, MS, BCPS, BCCCP, BCEMP, DPLA, FASHP, FCCP*
Clinical Pharmacy Coordinator - Emergency Medicine Pharmacy Residency Program Director
North Kansas City Hospital
Kansas City, Missouri
Gabrielle Procopio, PharmD, BCEMP
Emergency Medicine Clinical Pharmacist Specialist
Hackensack University Medical Center
Hackensack, New Jersey
Elizabeth Rozycki, PharmD, BCEMP
Specialty Practice Pharmacist, Emergency Medicine
The Ohio State University
Columbus, Ohio
Heather Tilley, PharmD, BCEMP
Clinical Pharmacy Specialist
The Johns Hopkins Hospital
Baltimore, Maryland
Elizabeth VanWert, PharmD, BCPS
Emergency Medicine Clinical Pharmacist
University of Michigan Health System
Ann Arbor, Michigan
David Zimmerman, PharmD, BCCCP, BCEMP, FASHP*
Associate Professor of Pharmacy
Duquesne University School of Pharmacy
Pittsburgh, Pennsylvania
* Content Matter Experts
Reviewers
Anna Jackson, PharmD, BCPS
Field Testers
Sam Abid, PharmD, BCPS, BCEMP
Emily Ankney, PharmD, BCCCP, BCEMP
Christina Aspinwall, PharmD, BCEMP
Jessica Barajas, PharmD, BCEMP
Michele Bender, PharmD, BCEMP
Zachary Benzio, PharmD, BCEMP
Eric Berg, PharmD, BCEMP
Katarina Bielinski, PharmD, BCEMP
Michelle Blesso, PharmD, BCEMP
Heather Blue, PharmD BCPS BCEMP
Jessica Boben, PharmD, BCPS, BCEMP
Justin Booth, PharmD, BCEMP
Kara Boyko Frandson, PharmD, BCPS, BCEMP
Stephen Bueno, PharmD, CPh, BCEMP
Teresa Calamas, PharmD
Anna Capulong, PharmD, BCPS, BCEMP
Taylor Cason, PharmD, CPP, BCPS, BCEMP
Justin Chung, PharmD, BCCCP, BCEMP
Tanya Claiborne, PharmD, BCEMP
Leah Clark, PharmD, BCEMP, SPI
Allison Clarke, PharmD, BCEMP, BCPS
Allison Clemens, PharmD, BCEMP
Craig Cocchio, PharmD, BCPS, BCEMP, DABAT
Quintin Conoly, PharmD, BCEMP
Bailey Constantine, PharmD, BCPS, BCCCP, BCEMP
Deanna Contreras, PharmD, BCEMP
Katelyn Corcoran, PharmD, BCEMP
Jessica Corio, PharmD, BCEMP
Sabrina Curtis, PharmD, BCEMP
Sarah DiVello, PharmD, BCPS, BCEMP
Emily Dyer, PharmD, BCEMP, BCPS
Richard Fan, PharmD, BCPS, BCCCP, BCEMP
Haden Geiger, PharmD, BCEMP
Bryan Gendron, PharmD, BCEMP
Erin Gordon, PharmD, BCEMP
Allison Gorseth, PharmD, BCPS, BCEMP
Thomas Gregory, PharmD, BCPE, BCEMP
Yaqing Guo, PharmD, BCEMP
Christian Hardrick, PharmD, BCEMP
Kristi Hargrove, PharmD, BCEMP
Megan Heath, PharmD, BCPS, BCEMP
Julie Hoover, PharmD, BCPS, BCEMP
Danielle Hopwood, PharmD, BCPS, BCEMP
Nusrat Hossain, PharmD, BCEMP
Lindsay Jacobs, PharmD, MPH, BCCCP, BCEMP
Sarah Jaszcz, PharmD, BCEMP
Tara Jawaro, PharmD, BCPS
Vera Jiang, PharmD, BCPS, BCEMP
Ronny Krejci, PharmD, BCPS, BCEMP
Vivian Kum, PharmD, BCEMP
Robert Lasko, PharmD, BCPS, BCEMP
Madi Lebin, PharmD, BCEMP
Jenny Lee, PharmD, BCEMP
Amanda Lewis, PharmD, BCPS, BCEMP
Kelsey Lock, PharmD, BCEMP
Nicholas Massie, Pharm. D, BCPS, BCCCP, BCEMP
Michael Mearis, PharmD
Meghan Miller, PharmD, BCEMP
Emily Montgomery, PharmD, BCEMP
Matthew Morrison, PharmD, BCPS, BCEMP
Mahmoud Nasiri, PharmD, BCPS, BCEMP
Daniel Nassif, PharmD, BCPS, BCEMP
Luke Neff, PharmD, BCEMP
Jonny Nguyen, PharmD, BCPS, BCEMP
Tara Parish, PharmD, BCPS, BCCCP, BCEMP
Caitlyn Patton, PharmD, BCEMP
April Pedder, PharmD, BCPS, BCEMP
John Phillips, PharmD, BCCCP, BCEMP
Cody Pitts, PharmD, BCPS, BCEMP
Alexas Polk, PharmD, BCEMP
Andrew Posen, PharmD, BCEMP
Brielle Reardon, PharmD, BCEMP
Roger Reeder, PharmD, BCPS, BCEMP
Alyssa Robertson, PharmD, BCPS, BCCCP, BCEMP
Erin Sadek, PharmD, BCEMP
Cecilia Schowe, PharmD, MS, BCPS, BCEMP
Kyle Schuchter, PharmD, BCEMP
Andrea Setiawan, PharmD, BCPS, BCEMP
Ashley Sii, PharmD, BCPS, BCEMP
Allison Simmons, PharmD, BCEMP
Natalie Slusarenko, PharmD, BCEMP
Patrick Joe Spillane, Pharm.D,, BCEMP
Lauren Stordahl, PharmD, BCPS, BCEMP
Louisa Sullivan, PharmD, BCPS, BCEMP
Elizabeth Svelund, PharmD, BCPS, BCEMP
Montana Tonnies, PharmD, BCEMP
Amanda Vanderwerf, PharmD, BCEMP
Samantha Wagner O'Doherty, PharmD, BCEMP
Karin Walton, PharmD, BCEMP
Haley Watson, PharmD, BCEMP
Daijah Wesley, PharmD, BCEMP
Holly Westerkamp, PharmD, MBA, BCEMP
Abigail Zeiner, PharmD, BCPS, BCEMP
Joseph Zerka, PharmD, BCEMP
Andrew Zwerlein, PharmD, BCPS, BCEMP
Relevant Financial Relationship Disclosures
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.
Methods and CE Requirements
Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:
- Complete the attestation statement
- Review all content
- Complete and pass the assessments
- Complete the evaluations
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Development
ASHP and ACCP collaborate on emergency medicine activities.
.
